HALB (Halberd) YoY EBITDA Growth: 66.67% (As of Jul. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Halberd YoY EBITDA Growth?

Halberd HALB -5.88% YoY EBITDA Growth is 66.67% as of Jul. 2023.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Halberd's YoY EBITDA Growth for the quarter that ended in Jul. 2023 was 66.67%.

Halberd's EBITDA per Share for the six months ended in Jul. 2023 was $-0.00.

Halberd YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Halberd's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Halberd YoY EBITDA Growth Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
YoY EBITDA Growth
0.00 -50.00 66.67

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
YoY EBITDA Growth 0.00 -50.00 66.67

Halberd YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Halberd's YoY EBITDA Growth for the fiscal year that ended in Jul. 2023 is calculated as:

YoY EBITDA Growth (A: Jul. 2023 )
=(EBITDA per Share (A: Jul. 2023 )-EBITDA per Share (A: Jul. 2022 ))/ | EBITDA per Share (A: Jul. 2022 ) |
=(-0.001--0.003)/ | -0.003 |
=66.67 %

Halberd's YoY EBITDA Growth for the quarter that ended in Jul. 2023 is calculated as:

YoY EBITDA Growth (Q: Jul. 2023 )
=(EBITDA per Share (Q: Jul. 2023 )-EBITDA per Share (Q: Jul. 2022 )) / | EBITDA per Share (Q: Jul. 2022 ) |
=(-0.001--0.003)/ | -0.003 |
=66.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 66.67% mean?
Halberd (HALB) has a YoY EBITDA Growth of 66.67% as of Jul. 2023. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Halberd and its competitors.
Is Halberd's YoY EBITDA Growth too high?
Halberd's current YoY EBITDA Growth is 66.67%.
How does Halberd's YoY EBITDA Growth compare to GRI and OCEA?
Halberd's YoY EBITDA Growth of 66.67% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Biotechnology company?
A good YoY EBITDA Growth depends on the Biotechnology industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Halberd and its competitors. Halberd's current YoY EBITDA Growth is 66.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Halberd stock overvalued right now?
Halberd (HALB) has a current YoY EBITDA Growth of 66.67%. The current YoY EBITDA Growth is 66.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Halberd (HALB), the current YoY EBITDA Growth is 66.67% as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Halberd Business Description

Address P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.